Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4L pseudogene 5 (MTND4LP5) is a nuclear pseudogene that contains sequence homology to the functional *MT-ND4L* gene, which encodes a subunit (ND4L) of mitochondrial Complex I. As a pseudogene, MTND4LP5 does not produce a functional protein and is not involved in mitochondrial respiratory chain activity or human disease. Nuclear pseudogenes of mitochondrial genes can be detected in genetic analyses but do not replace or compensate for defective mitochondrial genes. The canonical, functional gene *MT-ND4L* encodes a core subunit of Complex I of the mitochondrial respiratory chain, which is essential for electron transport and ATP production. Disease-causing mutations in the *functional* MT-ND4L gene are implicated in Leber hereditary optic neuropathy and certain mitochondrial disorders, but this does not apply to pseudogenes. Pseudogenes like MT-ND4L pseudogene 5 are segments embedded in the nuclear genome that have accumulated disabling mutations (e.g., premature stop codons), preventing them from producing functional protein subunits. Such pseudogenes may result in misleading PCR or sequencing signals, especially in cells lacking mitochondrial DNA, but they do not code for drug targets, nor do they participate in signaling, metabolism, or recognized disease pathways. There is currently no evidence or clinical relevance for drugs targeting MT-ND4L pseudogene 5, nor is it considered in patient selection or as a biomarker. As a pseudogene, it does not encode a receptor, enzyme, or other legitimate therapeutic target. Its only relevance is in genetic or molecular diagnostic contexts, where pseudogene sequences may confound results in mitochondrial DNA analysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4L pseudogene 5 (MTND4LP5).